.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Tolterodine tartrate - Generic Drug Details

« Back to Dashboard
Tolterodine tartrate is the generic ingredient in three branded drugs marketed by Ivax Sub Teva Pharms, Macleods Pharms Ltd, Torrent Pharms Ltd, Pharmacia And Upjohn, Mylan Pharms Inc, and Apotex Corp, and is included in eight NDAs. There are three patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are twenty-three drug master file entries for tolterodine tartrate. Sixteen suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for Generic Name: tolterodine tartrate

Tradenames:3
Patents:3
Applicants:6
NDAs:8
Drug Master File Entries: see list23
Suppliers / Packaging: see list16
Therapeutic Class:Genitourinary Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: tolterodine tartrate

Tentative approvals for TOLTERODINE TARTRATE

Applicant Application No. Form Dosage
<disabled><disabled>TABLET; ORAL1MG
<disabled><disabled>TABLET; ORAL2MG
<disabled><disabled>TABLET; ORAL1MG
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Torrent Pharms Ltd
TOLTERODINE TARTRATE
tolterodine tartrate
CAPSULE, EXTENDED RELEASE;ORAL203016-002Aug 11, 2015RXNo► subscribe► subscribe
Ivax Sub Teva Pharms
TOLTERODINE TARTRATE
tolterodine tartrate
TABLET;ORAL077006-002Feb 23, 2015RXNo► subscribe► subscribe
Apotex Corp
TOLTERODINE TARTRATE
tolterodine tartrate
TABLET;ORAL200164-001Sep 25, 2012RXNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: tolterodine tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn
DETROL
tolterodine tartrate
TABLET;ORAL020771-002Mar 25, 19985,382,600*PED► subscribe
Pharmacia And Upjohn
DETROL LA
tolterodine tartrate
CAPSULE, EXTENDED RELEASE;ORAL021228-001Dec 22, 20005,382,600*PED► subscribe
Pharmacia And Upjohn
DETROL
tolterodine tartrate
TABLET;ORAL020771-002Mar 25, 19985,550,269*PED► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc